Cambridge Investment Research Advisors, Inc. Iovance Biotherapeutics, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $27.1 Billion
- Q2 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 36,334 shares of IOVA stock, worth $380,053. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,334
Previous 27,260
33.29%
Holding current value
$380,053
Previous $404,000
27.97%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IOVA
# of Institutions
320Shares Held
238MCall Options Held
1.27MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA26MShares$271 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY25.9MShares$271 Million6.02% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$251 Million28.39% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$222 Million0.0% of portfolio
-
State Street Corp Boston, MA12.6MShares$132 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.65B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...